← All trials
NCT00845533
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2007
- Primary completion
- Dec 1, 2007
- Completion date
- Jan 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- —
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- University of California, San FranciscoLead sponsor
- Mahidol UniversityCollaborator
- University of California, San FranciscoOverall official - principal investigator
- Institut de Receherche en Sciences de la Sante Bobo-DioulassoOverall official - principal investigator
- University of California, San FranciscoReponsible party - principal investigator
- BEIJING HOLLEY-COTEC PHARMACEUTICALS CO. LTD.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.